首页> 外文OA文献 >Formulation of Nonionic Surfactant Vesicles (NISV) prepared by microfluidics for therapeutic delivery of siRNA into cancer cells
【2h】

Formulation of Nonionic Surfactant Vesicles (NISV) prepared by microfluidics for therapeutic delivery of siRNA into cancer cells

机译:通过微流控技术制备的用于将siRNA治疗性递送至癌细胞的非离子表面活性剂囊(NISV)的配方

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Small interfering RNAs (siRNA) have a broad potential as therapeutic agents to reversibly silence any target gene of interest. The clinical application of siRNA requires the use of safe and effective delivery systems. In this study, we investigated the use of nonionic surfactant vesicles (NISV) for the delivery of siRNA. Different types of NISV formulations were synthesized by microfluidic mixing and then evaluated for their physiochemical properties and cytotoxicity. The ability of the NISV to carry and transfect siRNA targeting green fluorescent protein (GFP) into A549 that stably express GFP (copGFP-A549) was evaluated. Flow cytometry and Western blotting were used to study the GFP expression knockdown, and significant knockdown was observed as a result of siRNA delivery to the cells by NISV. This occurred in particular when using Tween 85, which was able to achieve more than 70% GFP knockdown. NISV were thus demonstrated to provide a promising and effective platform for therapeutic delivery of siRNA.
机译:小干扰RNA(siRNA)作为治疗剂具有可逆性沉默任何目标基因的广泛潜力。 siRNA的临床应用要求使用安全有效的递送系统。在这项研究中,我们调查了使用非离子表面活性剂囊泡(NISV)传递siRNA。通过微流体混合合成了不同类型的NISV制剂,然后对其理化性质和细胞毒性进行了评估。评价了NISV将靶向绿色荧光蛋白(GFP)的siRNA携带并转染到稳定表达GFP(copGFP-A549)的A549中的能力。流式细胞仪和Western印迹用于研究GFP表达的敲低,并且观察到由于NISV siRNA递送至细胞而导致的明显敲低。特别是在使用Tween 85时,发生了这种情况,它能够实现超过70%的GFP敲低。因此,NISV被证明为siRNA的治疗性输送提供了一个有前途的有效平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号